Skip to main content
TrialFinder
TrialFinder is for informational purposes only and does not provide medical advice. Always talk to your doctor about whether a trial is right for you.

Crohn Disease (CD) Clinical Trials

17 recruiting trials for Crohn Disease (CD). Eligibility criteria explained in plain English.

Important: This information is not medical advice. Talk to your doctor about whether a clinical trial is right for you.
17
Total Trials
17
Recruiting Now
0
Phase 3 Trials
10
Sponsors

Recruiting Trials

RECRUITINGNCT06862843

Study on Eating Habits and Association with "omic" Profiles in Families with a Subject Affected by a Chronic...

The proposed study is part of a PNRR 2022 project (call "Non-Communicable Chronic Diseases (NCDs) with high impact on healthcare and social assistance systems," currently awaiting...

Sponsor: Meyer Children's Hospital IRCCSEnrolling: 904 locations
RECRUITINGNCT07224113

Assessment and Educational Intervention to Reduce Ultra-processed Food Consumption in Pediatric Patients With IBD

This study explores whether simple nutrition education can help children and teens with inflammatory bowel disease (IBD) eat fewer ultra-processed foods (UPFs). UPFs include...

Sponsor: Connecticut Children's Medical CenterEnrolling: 1201 location
RECRUITINGPhase 2NCT06604260

FAPi-PET Imaging of in Vivo Fibrosis in Inflammatory Bowel Disease Patients

Our main objective is to evaluate the feasibility of 68Ga-FAPi PET/CT in detecting intestinal fibrosis in patients with IBD. To this end, we will determine 68Ga-FAPi uptake in IBD...

Sponsor: Dalia LarteyEnrolling: 201 location
RECRUITINGPhase 1 / Phase 2NCT06606808

Fluorescence Imaging of Risankizumab-800CW in Inflammatory Bowel Disease

Crohn\'s Disease (CD) and Ulcerative Colitis (UC) are chronic inflammatory bowel diseases (IBD). Risankizumab is a human monoclonal antibody against IL23 p19, part of a...

Sponsor: University Medical Center GroningenEnrolling: 181 location
RECRUITINGPhase 4NCT07303686

De-escalation of Ustekinumab Therapy in Patients With Crohn's Disease and Ulcerative Colitis

The goal of this clinical trial is to evaluate whether disease remission can be maintained when biologic therapy is reduced in patients with Crohn"s disease (CD) and ulcerative...

Sponsor: McGill University Health Centre/Research Institute of the McGill University Health CentreEnrolling: 1151 location
RECRUITINGNCT06858553

AI-Assisted MRE for Intestinal Fibrosis in Crohn's Disease

Intestinal fibrotic strictures represent a severe complication of Crohn's disease (CD), affecting over half of the patients. Despite the continuous emergence of novel medications,...

Sponsor: Minhu ChenEnrolling: 2345 locations
RECRUITINGNCT06833450

Reliability of IUS in Crohn's Disease

Transabdominal intestinal ultrasound (IUS) is gaining acceptance as a point-of-care test to objectively assess disease activity in Crohn's disease (CD). In order to incorporate...

Sponsor: Centre Hospitalier Universitaire, AmiensEnrolling: 301 location
RECRUITINGNCT06727253

Glycan Supplementation on a Human Model of Crohn's Disease Initiation and Progression

The overall aim of this proof-of-concept trial is to investigate the effect of an orally administered glycan on the modulation of the dysregulation of host-microbiome interactions...

Sponsor: GLSMED Learning Health S.A.Enrolling: 301 location
RECRUITINGNCT05414578

NORDTREAT Prospective Study on Inflammatory Bowel Disease

Inflammatory bowel disease (IBD), primarily ulcerative colitis (UC) and Crohn's disease (CD), is a chronic disease entity affecting individuals of all ages, and which may severely...

Sponsor: University of Southern DenmarkEnrolling: 80017 locations
RECRUITINGNCT06758024

PROactive and Early Infliximab Monitoring and OPTimization in Inflammatory Bowel Disease

Infliximab (IFX) is a Food and Drug administration (FDA)-appoved monoclonal antibody medication targeting tumor necrosis factor (TNF) widely used in inflammatory bowel disease...

Sponsor: Pontificia Universidad Catolica de ChileEnrolling: 721 location
RECRUITINGNCT07441447

Evaluation of Muscle Strength and Muscle Mass in Patients With Inflammatory Bowel Disease

This prospective observational study aims to evaluate the validity of ultrasonographic muscle measurements in patients with inflammatory bowel disease (IBD). Sarcopenia is...

Sponsor: Sakarya UniversityEnrolling: 1001 location
RECRUITINGNCT07261826

Real-World Study on Fecal Microbiota Transplantation: Long-Term Effectiveness and Safety Statistics

This is a large-scale observational study aiming to evaluate the long-term effectiveness and safety of Fecal Microbiota Transplantation (FMT). FMT is a procedure that transfers...

Sponsor: Chen QiYiEnrolling: 40001 location
RECRUITINGNCT07013578

TIDHI Mental Health in IBD Patients Study

The purpose of this study is to test the impact of Healing Circuits™; a structured mental health support model on IBD patients. The eligible study participants will be randomly...

Sponsor: TIDHI Innovation Inc.Enrolling: 1001 location
RECRUITINGPhase 2NCT06925061

Target Engagement of EXL01 in the Prevention of Post-operative Recurrence of Crohn's Disease

MAINTAIN-POP is a Phase 2, randomised, double-blind, placebo-controlled, multicenter study of the impact of oral administration of EXL01 in the prevention of post-operative...

Sponsor: Madeleine BezaultEnrolling: 8012 locations
RECRUITINGNCT07089420

ALPCO/Calprotectin CLIA Assay: Expected Values of Calprotectin in Healthy Subjects

This study is evaluating the levels of calprotectin, a protein found in stool, in healthy adults. Calprotectin is a marker of inflammation in the intestines and can help doctors...

Sponsor: American Laboratory Products CompanyEnrolling: 1201 location
RECRUITINGNCT06896305

Impact of Exclusion Diet in Addition to Anti-TNF Therapy in Crohn's Disease and Ulcerative Colitis: a Prospective,...

This clinical study protocol aims to prospectively compare the efficacy of standard therapy with anti-TNF agents combined with the Crohn's Disease Exclusion Diet (CDED) versus...

Sponsor: IRCCS Ospedale San RaffaeleEnrolling: 801 location
RECRUITINGNCT01277419

German Spondyloarthritis Inception Cohort

The German Spondyloarthritis Inception cohort (GESPIC) was started 2000 as a prospective, longitudinal, multicentre, nationwide study in Germany on patients with early SpA...

Sponsor: Charite University, Berlin, GermanyEnrolling: 10001 location